Skip to main content
. 2009 Oct 31;53(1):58–65. doi: 10.1007/s00125-009-1571-9

Table 1.

Baseline characteristics of the patients with type 2 diabetes and the control group

Characteristic Baseline Follow-up
Type 2 diabetes Control group p value Type 2 diabetes Control group p value
n 68 38 68 38
Age (years) 65.6 ± 5.6 64.8 ± 4.8 0.44 69.8 ± 5.6 68.9 ± 4.8 0.44
Male sex (n) 32 (47%) 19 (50%) 0.77
Educational level (median (IQR)) 4 (3–5) 4 (4–5) 0.87
Estimated IQ (points) 100 ± 16 103 ± 13 0.39 97 ± 15 98 ± 15 0.64
Diabetes duration (years) 9.1 ± 6.3
HbA1c (%) 6.9 ± 1.1 5.5 ± 0.3 <0.001 7.2 ± 1.0 5.7 ± 0.4 <0.001
Hypertensiona 49 (72%) 11 (29%) <0.001 53 (78%) 19 (50%) <0.01
BMI (kg/m2) 27.9 ± 4.0 26.7 ± 5.2 0.19 28.4 ± 4.8 26.7 ± 4.5 0.09
Total cholesterol (mmol/l) 5.0 ± 0.9 5.9 ± 1.2 <0.001 4.5 ± 1.0 5.9 ± 1.0 <0.001
History of stroke 3 (4%) 1 (3%) 0.65 3 (4%) 1 (3%) 0.65
Any macrovascular eventb 18 (27%) 2 (5%) 0.007 20 (29%) 3 (8%) 0.01
Beck Depression Inventory 7.2 ± 5.0 4.4 ± 3.5 0.005 8.5 ± 7.0 5.5 ± 5.1 0.03
Beck Depression Inventory >13 5 (9%) 0 (0%) 0.07 9 (16%) 1 (3%) 0.04

Data are presented as mean ± SD or n (%) unless otherwise specified

aDefined as systolic blood pressure >160 mmHg, diastolic blood pressure >95 mmHg or use of blood-pressure-lowering medication

bDefined as a history of myocardial infarction, stroke, or surgery or endovascular treatment for coronary, carotid of peripheral (legs, abdominal aorta) artery disease

p values derived using univariate analysis of variance

IQR, interquartile range